Lupin receives final approval for Olmesartan Medoxomil tablets
From USFDA
Lupin announced that it has received final approval for its Olmesartan Medoxomil tablets, 5 mg, 20 mg and 40 mg from the United States Food and Drug Administration to market generic version of Benicar tablets, 5mg, 20 mg and 40 mg. It is indicated for the treatment of hypertension to lower blood pressure.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content